Gingipain cysteine proteinase (Gingipains)

Gingipain cysteine proteinase refers to a family of secreted and surface-anchored cysteine proteases, including lysine-gingipain (Kgp) and arginine-gingipain (RgpA, RgpB), produced by Porphyromonas gingivalis, a major pathogen in periodontal disease[2][7][1]. These enzymes account for the majority of proteolytic activity in P. gingivalis and are central virulence factors responsible for degradation of host structural and immune proteins, facilitating bacterial nutrition, immune evasion, tissue colonization, and destruction associated with periodontitis[3][7][9]. Structurally, gingipains belong to the MEROPS C25 family within clan CD, with a caspase-hemoglobinase protein fold and unique substrate specificity for arginine and lysine residues[1][2][4][7]. Their critical role in periodontal disease makes them leading targets for novel therapeutic strategies, including specific peptide-based or covalent active-site inhibitors, although no gingipain-targeted drugs are yet approved for clinical use[2][8][5].

Other names

Lysine-gingipain (Kgp)Arginine-gingipain (RgpA, RgpB, HRgpA)GingipainsC25 family cysteine protease

Inhibitors bind to the active site of gingipains, blocking proteolytic activity either competitively, uncompetitively, or by covalent modification of catalytic cysteine residues Chloromethyl ketone and D-Phe-Phe-Arg-chloromethylketone act as irreversible inhibitors by covalently modifying the active site cysteine Peptide inhibitors (such as κ-casein peptides) inhibit enzyme activity by binding in the presence of substrate and modulating enzyme kinetics